Möller, M.; Schütte, W.; Turzer, S.; Seliger, B.; Riemann, D.
Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy. Cancers 2023, 15, 4873.
https://doi.org/10.3390/cancers15194873
AMA Style
Möller M, Schütte W, Turzer S, Seliger B, Riemann D.
Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy. Cancers. 2023; 15(19):4873.
https://doi.org/10.3390/cancers15194873
Chicago/Turabian Style
Möller, Miriam, Wolfgang Schütte, Steffi Turzer, Barbara Seliger, and Dagmar Riemann.
2023. "Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy" Cancers 15, no. 19: 4873.
https://doi.org/10.3390/cancers15194873
APA Style
Möller, M., Schütte, W., Turzer, S., Seliger, B., & Riemann, D.
(2023). Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy. Cancers, 15(19), 4873.
https://doi.org/10.3390/cancers15194873